These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 634112)

  • 1. [Absorbability and therapeutic effectiveness of tri-valent iron contained in iron-(III)-citrate and iron-(III)-hydroxide-carbohydrate complexes].
    Heinrich HC
    Med Welt; 1978 Mar; 29(13):532-7. PubMed ID: 634112
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioavailability of trivalent iron in oral iron preparations. Therapeutic efficacy and iron absorption from simple ferric compounds and high- or low-molecular weight ferric hydroxide-carbohydrate complexes.
    Heinrich HC
    Arzneimittelforschung; 1975 Mar; 25(3):420-6. PubMed ID: 1174047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of iron salts and ferric hydroxide-carbohydrate complexes.
    Geisser P; Müller A
    Arzneimittelforschung; 1987 Jan; 37(1A):100-4. PubMed ID: 3566862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equivalent bioavailability of iron from ferrous salts and a ferric polymaltose complex. Clinical and experimental studies.
    Jacobs P
    Arzneimittelforschung; 1987 Jan; 37(1A):113-6. PubMed ID: 3566865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Letter: Trivalent iron containing oral iron preparations.
    Heinrich HC
    Arzneimittelforschung; 1975 Jun; 25(6):975-6. PubMed ID: 1174335
    [No Abstract]   [Full Text] [Related]  

  • 6. Bioavailability and therapeutic efficacy of bivalent and trivalent iron preparations.
    Kaltwasser JP; Werner E; Niechzial M
    Arzneimittelforschung; 1987 Jan; 37(1A):122-9. PubMed ID: 3566867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of bio-availability, antianaemic efficacy, tolerance and drug costs in oral iron(II) and iron(III) preparations (author's transl)].
    Dietzfelbinger H; Kaboth W
    Med Klin; 1979 Nov; 74(48):1818-24. PubMed ID: 395435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of different iron compounds in the rat].
    Grassmann E
    Zentralbl Veterinarmed A; 1976 May; 23(04):292-306. PubMed ID: 822637
    [No Abstract]   [Full Text] [Related]  

  • 9. [Investigations of the bioavailability of iron from bi- and trivalent iron salts (author's transl)].
    Dietzfelbinger H; Kaboth W
    Med Klin; 1977 Apr; 72(15):654-9. PubMed ID: 853979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are ferric compounds useful in treatment of iron deficiency anemia?
    Arvas A; Gür E
    Turk J Pediatr; 2000; 42(4):352-3. PubMed ID: 11196760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical characterization of iron (III)-hydroxide-dextrin complexes. A comparative study of commercial preparations with alleged reproductions used in the examination of bioavailability.
    Erni I; Oswald N; Rich HW; Schneider W
    Arzneimittelforschung; 1984; 34(11):1555-9. PubMed ID: 6543130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral iron therapy in human subjects, comparative absorption between ferrous salts and iron polymaltose.
    Jacobs P; Johnson G; Wood L
    J Med; 1984; 15(5-6):367-77. PubMed ID: 6599114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ferrous sulfate reduces methyldopa absorption: methyldopa: iron complex formation as a likely mechanism.
    Campbell NR; Campbell RR; Hasinoff BB
    Clin Invest Med; 1990 Dec; 13(6):329-32. PubMed ID: 2078911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron absorption by human subjects from different iron fortification compounds added to Thai fish sauce.
    Walczyk T; Tuntipopipat S; Zeder C; Sirichakwal P; Wasantwisut E; Hurrell RF
    Eur J Clin Nutr; 2005 May; 59(5):668-74. PubMed ID: 15756294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemistry of nonheme iron in man. II. Absorption of iron.
    Bezkorovainy A
    Clin Physiol Biochem; 1989; 7(2):53-69. PubMed ID: 2667838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of iron(II) salts and iron(III) complexes on trace element status in children with iron-deficiency anemia.
    Sözmen EY; Kavakli K; Cetinkaya B; Akçay YD; Yilmaz D; Aydinok Y
    Biol Trace Elem Res; 2003 Jul; 94(1):79-86. PubMed ID: 12907830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron pharmacokinetics after administration of ferric-hydroxide-polymaltose complex in rats.
    Geisser P; Müller A
    Arzneimittelforschung; 1984; 34(11):1560-9. PubMed ID: 6543131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of the bioavailability of iron.
    Fritz JC; Pla GW; Harrison BN; Clark GA
    J Assoc Off Anal Chem; 1975 Sep; 58(5):902-5. PubMed ID: 1158832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of iron uptake from iron salts and chelates by divalent metal cations in intestinal epithelial cells.
    Yeung CK; Glahn RP; Miller DD
    J Agric Food Chem; 2005 Jan; 53(1):132-6. PubMed ID: 15631519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability and the mechanisms of intestinal absorption of iron from ferrous ascorbate and ferric polymaltose in experimental animals.
    Johnson G; Jacobs P
    Exp Hematol; 1990 Nov; 18(10):1064-9. PubMed ID: 2209759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.